Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

LAMIVUDINE AND ZIDOVUDINE

LAMIVUDINE; ZIDOVUDINE

Standard Dose
150MG;300MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LAMIVUDINE AND ZIDOVUDINE is listed in Drugs@FDA under application 206375 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LAMIVUDINE; ZIDOVUDINE Form and strength TABLET;ORAL - 150MG;300MG Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2019-09-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview LAMIVUDINE AND ZIDOVUDINE is listed in Drugs@FDA under application 206375 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LAMIVUDINE; ZIDOVUDINE Form and strength TABLET;ORAL - 150MG;300MG Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2019-09-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.